Dr. Rajnish Kumar
Also known as: RAJNISH SHUKLA
Noida Institute of Engineering and Technology
About
Dr Rajnish Kumar is an Associate Professor at Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida. The Technical Skills and Competencies of Dr. Kumar include Computer-Aided Drug Design (CADD) covering Small molecules
database (PubChem, ChEMBL, Zinc, DrugBank) mining, Cheminformatics (Molecular
descriptors DMPK profiling, Lipinski’s/ Ghose rule filtering, Molecular similarity
searching), Ligand-based (ADMET profiling, CoMFA/CoMSIA, Pharmacophore mapping),
Structure-based Analog Design (Molecular modeling, Protein structure prediction,
Docking-scoring, Binding cavity analysis) and Molecular dynamic simulations.
Employment
-
Noida Institute of Engineering and Technology Associate Professor2013 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (112)
- Utility of Palladium as a Catalyst for the Synthesis of Five and Six-Membered Heterocyclic Moieties Save
- Rechallenge Therapy: New Dimensions in Cancer Therapy Save
- Recent Trends in the Synthesis of Benzimidazoles and Use of the Phillips Modification. A Review Save
- Advances in Synthesis of Piperazine Analogues and Molecular Targets: Unlocking Their Potential in CNS Disorder Therapy Save
- Synthesis, in-vivo, ADMET prediction, molecular docking studies, MD simulation, and DFT analysis of novel 1,3,4-oxadiazole-furan hybrids as anticonvulsants Save
- Copper-catalyzed synthesis of heterocycles via single and two-electron pathways Save
- Synthesis and Structure-Activity Relationship of Pyrazoline Derivatives for Antimicrobial Applications: Current Insights Save
- Zwitterion: Important Tool for the Regioselective Synthesis of Five‑Membered Heterocycles: Mechanistic and Synthetic Perspectives Save
- Synergistic Anti-dementia Effects of Symplocos racemosa Nanoemulsion: Isolation, Molecular Docking, and In Vivo Evaluation Save
- Advances in Chemotherapeutic Potential of Glycoconjugates against Cancer Save